An official website of the United States government Here's how you know

The .gov means it's official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Report a Drug Shortage | FAQ | Background Info | Get Email Alerts | Download Current Drug Shortages | Contact Us

Start Over | Back to Previous Screen

Oxaliplatin Injection
Status: Discontinuation
»Therapeutic Categories: Oncology

Fresenius Kabi USA, LLC (New 02/25/2026)

Company Contact Information:
847-550-2300

Presentation	Posting Date	Related Information
Oxaliplatin, Injection, 5 mg/mL (NDC 63323-750-10)	02/25/2026	A business decision was made to discontinue manufacture of the drug.
Oxaliplatin, Injection, 5 mg/mL (NDC 63323-750-20)	02/25/2026	A business decision was made to discontinue manufacture of the drug.

Sandoz Inc. (New 10/20/2025)

Company Contact Information:
800-525-8747

Presentation	Posting Date	Related Information
Oxaliplatin, Injection, 5 mg/1 mL (NDC 0781-3315-70)	10/20/2025	Discontinuation of the manufacture of the drug
Oxaliplatin, Injection, 5 mg/1 mL (NDC 0781-3317-80)	10/20/2025	Discontinuation of the manufacture of the drug

Top